These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 1319518)

  • 1. Fifteen-S-hydroxyeicosatetraenoic acid (15-S-HETE) specifically antagonizes the chemotactic action and glomerular synthesis of leukotriene B4 in the rat.
    Fischer DB; Christman JW; Badr KF
    Kidney Int; 1992 May; 41(5):1155-60. PubMed ID: 1319518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 15-Hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits LTB4-induced chemotaxis of human neutrophils.
    Ternowitz T; Fogh K; Kragballe K
    Skin Pharmacol; 1988; 1(2):93-9. PubMed ID: 2856182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiinflammatory effects of second-generation leukotriene B4 receptor antagonist, SC-53228: impact upon leukotriene B4- and 12(R)-HETE-mediated events.
    Fretland DJ; Anglin CP; Bremer M; Isakson P; Widomski DL; Paulson SK; Docter SH; Djuric SW; Penning TD; Yu S
    Inflammation; 1995 Apr; 19(2):193-205. PubMed ID: 7601505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remodeling of neutrophil phospholipids with 15(S)-hydroxyeicosatetraenoic acid inhibits leukotriene B4-induced neutrophil migration across endothelium.
    Takata S; Matsubara M; Allen PG; Janmey PA; Serhan CN; Brady HR
    J Clin Invest; 1994 Feb; 93(2):499-508. PubMed ID: 7906693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of neutrophil chemotaxis by leukotriene B4 and 5-hydroxyeicosatetraenoic acid in chronic inflammatory bowel disease.
    Nielsen OH; Elmgreen J
    Scand J Clin Lab Invest; 1987 Oct; 47(6):605-11. PubMed ID: 2823370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of hydroxyeicosatetraenoic acids and leukotrienes in rat nephrotoxic serum glomerulonephritis. Role of anti-glomerular basement membrane antibody dose, complement, and neutrophiles.
    Lianos EA
    J Clin Invest; 1988 Aug; 82(2):427-35. PubMed ID: 2841352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukotriene B4 production in human mononuclear phagocytes is modulated by interleukin-4-induced 15-lipoxygenase.
    Profita M; Sala A; Siena L; Henson PM; Murphy RC; Paternò A; Bonanno A; Riccobono L; Mirabella A; Bonsignore G; Vignola AM
    J Pharmacol Exp Ther; 2002 Mar; 300(3):868-75. PubMed ID: 11861792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 15-Lipoxygenase products as leukotriene antagonists: therapeutic potential in glomerulonephritis.
    Badr KF
    Kidney Int Suppl; 1992 Oct; 38():S101-8. PubMed ID: 1405359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional significance of leukotriene B4 in normal and glomerulonephritic kidneys.
    Yared A; Albrightson-Winslow C; Griswold D; Takahashi K; Fogo A; Badr KF
    J Am Soc Nephrol; 1991 Jul; 2(1):45-56. PubMed ID: 1655093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediation of leukocyte components of inflammatory reactions by lipoxygenase products of arachidonic acid.
    Goetzl EJ; Goldman DW; Naccache PH; Sha'afi RI; Pickett WC
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():273-82. PubMed ID: 6283846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-trans-leukotriene B4 is a neutrophil chemotaxin in the guinea pig dermis.
    Fretland DJ; Widomski DL; Anglin CP; Walsh RE; Levin S; Gaginella TS
    J Leukoc Biol; 1991 Mar; 49(3):283-8. PubMed ID: 1847716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoxygenase product formation and cell adhesion during neutrophil-glomerular endothelial cell interaction.
    Brady HR; Lamas S; Papayianni A; Takata S; Matsubara M; Marsden PA
    Am J Physiol; 1995 Jan; 268(1 Pt 2):F1-12. PubMed ID: 7840235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 15-Hydroxy-eicosatetraenoic acid (15-HETE) inhibits carrageenan-induced experimental arthritis and reduces synovial fluid leukotriene B4 (LTB4).
    Fogh K; Hansen ES; Herlin T; Knudsen V; Henriksen TB; Ewald H; Bünger C; Kragballe K
    Prostaglandins; 1989 Feb; 37(2):213-28. PubMed ID: 2543035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukotriene B4 production by the human alveolar macrophage: a potential mechanism for amplifying inflammation in the lung.
    Martin TR; Altman LC; Albert RK; Henderson WR
    Am Rev Respir Dis; 1984 Jan; 129(1):106-11. PubMed ID: 6322626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 15(S)-HETE modulates LTB(4) production and neutrophil chemotaxis in chronic bronchitis.
    Profita M; Sala A; Riccobono L; Pace E; Paternò A; Zarini S; Siena L; Mirabella A; Bonsignore G; Vignola AM
    Am J Physiol Cell Physiol; 2000 Oct; 279(4):C1249-58. PubMed ID: 11003605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil degranulation: evidence pertaining to its mediation by the combined effects of leukotriene B4, platelet-activating factor, and 5-HETE.
    O'Flaherty JT
    J Cell Physiol; 1985 Feb; 122(2):229-39. PubMed ID: 2981891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linoleic acid and dihomogammalinolenic acid inhibit leukotriene B4 formation and stimulate the formation of their 15-lipoxygenase products by human neutrophils in vitro. Evidence of formation of antiinflammatory compounds.
    Iversen L; Fogh K; Bojesen G; Kragballe K
    Agents Actions; 1991 Jul; 33(3-4):286-91. PubMed ID: 1659156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE) and 5,12-dihydroxyeicosatetraenoic acid (leukotriene B4) in psoriasis and normal human skin.
    Dowd PM; Black AK; Woollard PW; Greaves MW
    Arch Dermatol Res; 1987; 279(7):427-34. PubMed ID: 2829751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 15-hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits the LTB4-induced skin response.
    Ternowitz T; Andersen PH; Bjerring P; Fogh K; Schröder JM; Kragballe K
    Arch Dermatol Res; 1989; 281(6):401-5. PubMed ID: 2556975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696.
    Showell HJ; Pettipher ER; Cheng JB; Breslow R; Conklyn MJ; Farrell CA; Hingorani GP; Salter ED; Hackman BC; Wimberly DJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):176-84. PubMed ID: 7714764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.